Insider Trading & Ownership - Lin Shao-Lee

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lin Shao-Lee
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-04-01
Sale
2024-04-03
6:18 pm
ACELYRIN Inc.SLRNLin Shao-Lee
Chief Executive Officer
9,961$6.6283$66,0243,452,329
(Indirect
Direct)
View
2024-02-20
Sale
2024-02-22
7:04 pm
ACELYRIN Inc.SLRNLin Shao-Lee
Chief Executive Officer
15,701$7.6048$119,4033,462,290
(Indirect
Direct)
View
2024-01-02
Sale
2024-01-04
6:09 pm
ACELYRIN Inc.SLRNLin Shao-Lee
Chief Executive Officer
10,691$7.407$79,1883,477,991
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-09
Option Award
2024-01-11
6:42 pm
N/A
2034-01-08
ACELYRIN Inc.SLRNLin Shao-Lee
Chief Executive Officer
1,378,327$01,378,327
(Direct)
View
2023-10-04
Other
2023-10-06
5:55 pm
N/A
N/A
ACELYRIN Inc.SLRNLin Shao-Lee
Chief Executive Officer
1,293,983$04,781,372
(Indirect)
View
2023-08-16
Option Award
2023-08-18
6:49 pm
N/A
N/A
ACELYRIN Inc.SLRNLin Shao-Lee
Chief Executive Officer
842,400$04,516,900
(Direct)
View
2023-05-18
Option Award
2023-05-19
6:31 pm
2023-06-18
2033-05-18
Surrozen Inc.SRZNLin Shao-Lee
Director
20,000$020,000
(Direct)
View
2023-05-09
Tax Withholding
2023-05-11
8:50 pm
N/A
N/A
ACELYRIN Inc.SLRNLin Shao-Lee
Chief Executive Officer
337,179$24.697,249,756
(Direct)
View
2023-05-09
Conversion
2023-05-11
8:50 pm
N/A
N/A
ACELYRIN Inc.SLRNLin Shao-Lee
Chief Executive Officer
2,323,494$07,249,756
(Indirect)
View
2023-05-09
Other
2023-05-11
8:50 pm
N/A
2033-05-03
ACELYRIN Inc.SLRNLin Shao-Lee
Chief Executive Officer
4,044,539$07,249,756
(Direct)
View
2023-05-04
Option Award
2023-05-04
7:57 pm
N/A
2033-05-03
ACELYRIN Inc.SLRNLin Shao-Lee
Chief Executive Officer
774,788$0774,788
(Direct)
View

Ownership
2023-05-04
6:43 pm
N/A
N/A
ACELYRIN Inc.SLRNLin Shao-Lee
Chief Executive Officer
0$04,011,679
(Direct)
View
2022-10-26
Option Award
2022-10-27
4:57 pm
N/A
2032-10-25
Third Harmonic Bio Inc.THRDLin Shao-Lee
Director
13,667$013,667
(Direct)
View

Ownership
2022-09-14
6:15 pm
N/A
2030-09-13
Third Harmonic Bio Inc.THRDLin Shao-Lee
Director
0$095,259
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:49 pm
2023-06-07
2032-06-07
Surrozen Inc.SRZNLin Shao-Lee
Director
20,000$020,000
(Direct)
View

Ownership
2021-08-16
7:47 pm
N/A
N/A
Surrozen Inc.SRZNLin Shao-Lee
Director
0$035,129
(Direct)
View
2020-09-28
Disposition
2020-09-28
5:25 pm
N/A
2029-04-15
Principia Biopharma Inc.PRNBLin Shao-Lee
Director
40,955$00
(Direct)
View
2020-06-04
Option Award
2020-06-08
8:05 pm
N/A
2030-06-03
Principia Biopharma Inc.PRNBLin Shao-Lee
Director
10,240$010,240
(Direct)
View
2020-01-21
Tax Withholding
2020-01-23
4:22 pm
N/A
N/A
Horizon Therapeutics Public Ltd CoHZNPLin Shao-Lee
EVP, Head of R&D and CSO
2,716$38.25121,930
(Direct)
View
2020-01-21
Option Award
2020-01-23
4:22 pm
N/A
N/A
Horizon Therapeutics Public Ltd CoHZNPLin Shao-Lee
EVP, Head of R&D and CSO
18,391$0121,930
(Direct)
View
2020-01-03
Option Award
2020-01-07
6:21 pm
N/A
N/A
Horizon Therapeutics Public Ltd CoHZNPLin Shao-Lee
EVP, Head of R&D and CSO
71,936$0246,652
(Direct)
View
2020-01-04
Tax Withholding
2020-01-07
6:21 pm
N/A
N/A
Horizon Therapeutics Public Ltd CoHZNPLin Shao-Lee
EVP, Head of R&D and CSO
46,213$36.1246,652
(Direct)
View
2020-01-04
Exercise
2020-01-07
6:21 pm
N/A
N/A
Horizon Therapeutics Public Ltd CoHZNPLin Shao-Lee
EVP, Head of R&D and CSO
118,580$0246,652
(Direct)
View
2019-06-11
Option Award
2019-06-11
6:57 pm
N/A
2029-06-10
Principia Biopharma Inc.PRNBLin Shao-Lee
Director
10,240$010,240
(Direct)
View